Two symposia on therapeutic vaccines against HIV/AIDS and dengue, and a session on genomics will open debates on Monday at the Biotechnology Conference Havana-2012, the inauguration of which will take place at the end of the day.
The event will consist of lectures given by Luis Herrera, head of the Genetic Engineering and Biotechnology Center (ICGEB) of Cuba, and by Peter Agre, a professor at the Johns Hopkins University School of Medicine, and also Nobel Prize winner in Chemistry in 2003.
Some 600 delegates from about 40 nations will participate in the forum to share a complex scientific agenda that includes topics on infectious diseases, cancer biology, proteomics, pharmacogenomics, and bioinformatics, in the search for new drugs.
The international conference will also discuss issues related to neurodegeneration and therapeutic achievements to treat cardiovascular and autoimmune diseases, and inflammation.
Cuban experts will present the results of important research works taking place in the country, as in the case of the therapeutic vaccine against hepatitis B, one of a kind worldwide. (Taken from PL).